Literature DB >> 15463558

Albendazole as a future antigiardial agent.

J A Reynoldson1, R C Thompson, R J Horton.   

Abstract

Albendazole, one of the more recently developed of the benzimidazole carbamate anthelmintics, has the broadest spectrum of activity of the benzimidazoles released to date. In this article, Jim Reynoldson, Andrew Thompson and John Horton discuss the role of this drug in the fight against giardiasis.

Entities:  

Year:  1992        PMID： 15463558     DOI： 10.1016/0169-4758(92)90193-6

Source DB:  PubMed          Journal:  Parasitol Today        ISSN： 0169-4758


  6 in total

1.  Survey of intestinal parasites in stray dogs in the Madrid area and comparison of the efficacy of three anthelmintics in naturally infected dogs.

Authors:  Guadalupe Miró; Marta Mateo; Ana Montoya; Enrique Vela; Rosa Calonge
Journal:  Parasitol Res       Date:  2006-08-17       Impact factor: 2.289

2.  Novel and promising compounds to treat Cryptosporidium parvum infections.

Authors:  Zofi Graczyk; Lidia Chomicz; Mariola Kozłowska; Zygmunt Kazimierczuk; Thaddeus K Graczyk
Journal:  Parasitol Res       Date:  2011-02-23       Impact factor: 2.289

Review 3.  Treatment of giardiasis.

Authors:  T B Gardner; D R Hill
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

4.  Albendazole inhibits Pneumocystis carinii proliferation in inoculated immunosuppressed mice.

Authors:  M S Bartlett; T D Edlind; C H Lee; R Dean; S F Queener; M M Shaw; J W Smith
Journal:  Antimicrob Agents Chemother       Date:  1994-08       Impact factor: 5.191

5.  Systematic search for benzimidazole compounds and derivatives with antileishmanial effects.

Authors:  Juan Carlos Sánchez-Salgado; Pablo Bilbao-Ramos; María Auxiliadora Dea-Ayuela; Francisco Hernández-Luis; Francisco Bolás-Fernández; José L Medina-Franco; Yareli Rojas-Aguirre
Journal:  Mol Divers       Date:  2018-05-10       Impact factor: 2.943

Review 6.  Parasitic diarrheal disease: drug development and targets.

Authors:  Amir Azam; Mudasir N Peerzada; Kamal Ahmad
Journal:  Front Microbiol       Date:  2015-10-27       Impact factor: 5.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.